The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease

Xuexian Fang1,2,3, Hossein Ardehali4, Junxia Min5

  • 1Department of Nutrition and Toxicology, School of Public Health, State Key Laboratory of Experimental Hematology, Hangzhou Normal University, Hangzhou, China.

Insights

Iron imbalance and ferroptosis are key factors in cardiovascular diseases. Understanding these processes in heart cells may lead to new treatments for conditions like heart failure and atherosclerosis.

Area of Science:

  • Cardiology
  • Cellular Biology
  • Biochemistry

Background:

  • Iron homeostasis is critical for heart function.
  • Iron imbalance is linked to various cardiovascular diseases.
  • Ferroptosis, an iron-dependent cell death, plays a role in cardiovascular pathology.

Purpose of the Study:

  • To review the role of iron metabolism and ferroptosis in cardiovascular disease.
  • To explore potential therapeutic targets for cardiovascular conditions.
  • To discuss future directions in ferroptosis-targeted cardiovascular treatments.

Main Methods:

  • Literature review of studies on iron metabolism and ferroptosis in cardiovascular disease.
  • Analysis of molecular and metabolic pathways involved.
  • Discussion of current research and clinical implications.

Main Results:

  • Ferroptosis is implicated in atherosclerosis, heart failure, ischemia-reperfusion injury, and diabetic cardiomyopathy.
  • Dysregulation of iron metabolism is a common factor in these conditions.
  • Targeting ferroptosis presents a novel therapeutic strategy for cardiovascular diseases.

Conclusions:

  • Understanding iron regulation and ferroptosis is crucial for managing cardiovascular diseases.
  • Targeting ferroptosis pathways offers promising therapeutic avenues.
  • Further research is needed to translate these findings into clinical practice.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
32
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
792
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
1.7K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
327
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31